Clinical Scorecard: Orthokeratology Today: Orthokeratology: What’s on the Horizon?
At a Glance
| Category | Detail |
|---|---|
| Condition | Myopia control |
| Key Mechanisms | Slows myopia progression by reducing axial elongation |
| Target Population | Children and young adults with myopia, hyperopia, and presbyopia |
| Care Setting | Optometry clinics |
Key Highlights
- Ortho-k lenses improve patient outcomes with advanced corneal mapping.
- Combination therapy with low-dose atropine enhances myopia control.
- Ortho-k is expanding to treat hyperopia and presbyopia.
- AI algorithms improve ortho-k fitting efficiency.
- Patient motivation and expectation management are crucial for success.
Guideline-Based Recommendations
Diagnosis
- Assess myopia progression and risk factors in children.
Management
- Consider ortho-k as a primary treatment for myopia control.
- Evaluate combination therapy with low-dose atropine for high-risk patients.
Monitoring & Follow-up
- Regularly monitor axial length and refractive changes in myopic patients.
Risks
- Combination therapies may not achieve 100% efficacy in myopia control.
Patient & Prescribing Data
Children with myopia, particularly those with rapid progression or high myopia.
Ortho-k is effective for myopia control and can be combined with atropine for enhanced results.
Clinical Best Practices
- Utilize advanced corneal mapping for custom ortho-k lens design.
- Incorporate AI tools to streamline lens fitting processes.
- Manage patient expectations to improve satisfaction and outcomes.
References
- Lipson et al, 2018
- Xu et al, 2023
- Tang et al, 2024
- Sánchez-González et al, 2020
- Sankaridurg et al, 2025
- Lan et al, 2024
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.